Loading...
News 2017-07-15T01:04:34+00:00

Categories

Archives

IVI’s Mark Linthicum in Morning Consult: Why Understanding Value is Central to True Health Care Reform

Mark Linthicum makes the case that value-based spending should be the focus of health care reform efforts in Washington, D.C. On September 13th health care stakeholders came together at the National Press Club to discuss [...]

September 20th, 2017|Viewpoints|

IVI-Sponsored Health Affairs Policymaker Forum Assembles Key Stakeholders

On September 13th, the Innovation and Value Initiative was proud to sponsor a special Health Affairs briefing in Washington, D.C. Over 200 of the country's most influential health care stakeholders and public policy thought leaders [...]

September 14th, 2017|Event|

Shafrin Defines Precision Medicine for U.S. News and World Report

In a new commentary for U.S. News and World Report, Jason Shafrin defines and elaborates on the field of precision medicine. Jason, IVI's Director of Research, illustrates how the United States is moving headlong into [...]

August 25th, 2017|Viewpoints|

IVI Highlighted in Article on Value Assessment in Oncology Treatments

In this month's Drug Topics, correspondent Kathleen Gannon Longo speaks with Jeremy Schafer about the potentially tremendous impact that value assessments will have on future patient reimbursement decisions. Focusing on Oncology treatment, Schafer describes some [...]

June 28th, 2017|Press|

Sachs Summarizes Recent HELP Committee Meeting: The Elephant in the Room

In the latest post on the the IVI-sponsored Health Affairs blog series, Rachel Sachs summarizes the recent Senate Health, Education, Labor & Pensions (HELP) Committee meeting. Organized to address the drug delivery system and how [...]

June 20th, 2017|Viewpoints|

IVI’s Lakdawalla in WSJ: Look to Major League Baseball for Drug Pricing Insight

In a new commentary appearing in The Wall Street Journal, Dana Goldman and IVI Executive Director, Darius Lakdawalla, turn to the national pastime to provide a fresh perspective on the issue of drug pricing and the [...]

June 19th, 2017|Viewpoints|

IVI Releases Protocol for Report on Cost-Effectiveness Analysis in Health Care

IVI released the research protocol for its first project, which examines the quality of evidence and methods used in cost-effectiveness analysis (CEA) in healthcare. The research protocol is available here. This is the first research project [...]

June 14th, 2017|Research|

Sood, Shih, Van Nuys and Goldman’s Study Details the Flow of Funds in Pharma’s Distribution System

In the latest post on the the IVI-sponsored Health Affairs blog series, Neeraj Sood, Tiffany Shih, Karen Van Nuys and Dana Goldman present the findings of their study examining the flow of funds in the [...]

June 13th, 2017|Viewpoints|